Skip to main content

Capecitabine News

Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer

THURSDAY, Nov. 16, 2023 – For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overall survival benefit,...

Zolbetuximab Plus CAPOX Beneficial for Advanced mG/GEJ Adenocarcinoma

FRIDAY, Sept. 1, 2023 – For patients with human epidermal growth factor receptor 2 (HER2)-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ)...

Findings of IDEA Collaboration Have Influenced Prescribing Patterns

WEDNESDAY, Aug. 9, 2023 – Changes in prescribing patterns for resected stage III colon cancer have been observed since the abstract presentation of the IDEA collaboration in June 2017, according to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Renal Cell Carcinoma

Capecitabine patient information at Drugs.com